Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 139Prostatic Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 10Motor Activity 8Ovarian Neoplasms 7Gastrointestinal Neoplasms 7Neoplasms 5Uterine Cervical Neoplasms 4Sarcoma 4Lymphoma 4Endometrial Neoplasms 4Depression 4Pain 3Hereditary Breast and Ovarian Cancer Syndrome 3Fatigue 3Colonic Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Anxiety Disorders 3Vomiting 2Thyroid Neoplasms 2Neoplasm Metastasis 2Melanoma 2Leukemia 2Hodgkin Disease 2Head and Neck Neoplasms 2Communication 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2

Interventions

Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Genetic Testing 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Breast × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡